Mural Oncology PLC (MURA)
(Delayed Data from NSDQ)
$2.08 USD
0.00 (0.00%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $2.08 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MURA 2.08 0.00(0.00%)
Will MURA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MURA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MURA
MURA Soars as it Explores Strategic Options Post Cancer Study Failures
MURA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MURA
Is MURA showing upside potential? 20 Day Moving Average Support shows up after a flat session
20 Day Moving Average Support appears for MURA after 0.0% move
20 Day Moving Average Support appears for MURA after 0.48% move
MURA forms Narrow Range Bar on September 16
MURA forms Narrow Range Bar on September 15